C165H256ClF3N42O13 — CID 161279583
2-[(6-tert-butylpyrimidin-4-yl)-methylamino]ethanol;2-chloro-4-methyl-6-propan-2-ylpyrimidine;2,4-dimethyl-6-propan-2-ylpyrimidine;2-[2-hydroxyethyl-(4-methyl-6-propan-2-ylpyrimidin-2-yl)amino]ethanol;[5-(hydroxymethyl)-1-(4-methyl-6-propan-2-ylpyrimidin-2-yl)pyrrolidin-2-yl]methanol;4-methoxy-2-methyl-6-propan-2-ylpyrimidine;2-methyl-5-propan-2-ylpyrazine;methyl 5-propan-2-ylpyrazine-2-carboximidate;methyl 6-propan-2-ylpyridazine-3-carboxylate;4-methyl-6-propan-2-ylpyrimidine;4-(4-methyl-6-propan-2-ylpyrimidin-2-yl)morpholine;4-methyl-6-propan-2-yl-2-(trifluoromethyl)pyrimidine;2-[4-(5-propan-2-ylpyrazin-2-yl)piperazin-1-yl]ethanol;4-(6-propan-2-ylpyridazin-3-yl)morpholine;1-(6-propan-2-ylpyrimidin-4-yl)piperidin-4-ol;4-propan-2-yl-6-pyrrolidin-1-ylpyrimidine (PubChem CID 161279583) has the molecular formula C165H256ClF3N42O13 and a molecular weight of 3128.59 g/mol. Its IUPAC name is 2-[(6-tert-butylpyrimidin-4-yl)-methylamino]ethanol;2-chloro-4-methyl-6-propan-2-ylpyrimidine;2,4-dimethyl-6-propan-2-ylpyrimidine;2-[2-hydroxyethyl-(4-methyl-6-propan-2-ylpyrimidin-2-yl)amino]ethanol;[5-(hydroxymethyl)-1-(4-methyl-6-propan-2-ylpyrimidin-2-yl)pyrrolidin-2-yl]methanol;4-methoxy-2-methyl-6-propan-2-ylpyrimidine;2-methyl-5-propan-2-ylpyrazine;methyl 5-propan-2-ylpyrazine-2-carboximidate;methyl 6-propan-2-ylpyridazine-3-carboxylate;4-methyl-6-propan-2-ylpyrimidine;4-(4-methyl-6-propan-2-ylpyrimidin-2-yl)morpholine;4-methyl-6-propan-2-yl-2-(trifluoromethyl)pyrimidine;2-[4-(5-propan-2-ylpyrazin-2-yl)piperazin-1-yl]ethanol;4-(6-propan-2-ylpyridazin-3-yl)morpholine;1-(6-propan-2-ylpyrimidin-4-yl)piperidin-4-ol;4-propan-2-yl-6-pyrrolidin-1-ylpyrimidine.
| Compound Name | 2-[(6-tert-butylpyrimidin-4-yl)-methylamino]ethanol;2-chloro-4-methyl-6-propan-2-ylpyrimidine;2,4-dimethyl-6-propan-2-ylpyrimidine;2-[2-hydroxyethyl-(4-methyl-6-propan-2-ylpyrimidin-2-yl)amino]ethanol;[5-(hydroxymethyl)-1-(4-methyl-6-propan-2-ylpyrimidin-2-yl)pyrrolidin-2-yl]methanol;4-methoxy-2-methyl-6-propan-2-ylpyrimidine;2-methyl-5-propan-2-ylpyrazine;methyl 5-propan-2-ylpyrazine-2-carboximidate;methyl 6-propan-2-ylpyridazine-3-carboxylate;4-methyl-6-propan-2-ylpyrimidine;4-(4-methyl-6-propan-2-ylpyrimidin-2-yl)morpholine;4-methyl-6-propan-2-yl-2-(trifluoromethyl)pyrimidine;2-[4-(5-propan-2-ylpyrazin-2-yl)piperazin-1-yl]ethanol;4-(6-propan-2-ylpyridazin-3-yl)morpholine;1-(6-propan-2-ylpyrimidin-4-yl)piperidin-4-ol;4-propan-2-yl-6-pyrrolidin-1-ylpyrimidine |
|---|---|
| PubChem CID | 161279583 |
| Molecular Formula | C165H256ClF3N42O13 |
| Molecular Weight | 3128.59 g/mol |
| Exact Mass | 3126.03 |
| IUPAC Name | 2-[(6-tert-butylpyrimidin-4-yl)-methylamino]ethanol;2-chloro-4-methyl-6-propan-2-ylpyrimidine;2,4-dimethyl-6-propan-2-ylpyrimidine;2-[2-hydroxyethyl-(4-methyl-6-propan-2-ylpyrimidin-2-yl)amino]ethanol;[5-(hydroxymethyl)-1-(4-methyl-6-propan-2-ylpyrimidin-2-yl)pyrrolidin-2-yl]methanol;4-methoxy-2-methyl-6-propan-2-ylpyrimidine;2-methyl-5-propan-2-ylpyrazine;methyl 5-propan-2-ylpyrazine-2-carboximidate;methyl 6-propan-2-ylpyridazine-3-carboxylate;4-methyl-6-propan-2-ylpyrimidine;4-(4-methyl-6-propan-2-ylpyrimidin-2-yl)morpholine;4-methyl-6-propan-2-yl-2-(trifluoromethyl)pyrimidine;2-[4-(5-propan-2-ylpyrazin-2-yl)piperazin-1-yl]ethanol;4-(6-propan-2-ylpyridazin-3-yl)morpholine;1-(6-propan-2-ylpyrimidin-4-yl)piperidin-4-ol;4-propan-2-yl-6-pyrrolidin-1-ylpyrimidine |
| SMILES | CC(C)c1cc(N2CCC(O)CC2)ncn1.CC(C)c1cc(N2CCCC2)ncn1.CC(C)c1ccc(N2CCOCC2)nn1.CC(C)c1cnc(N2CCN(CCO)CC2)cn1.CN(CCO)c1cc(C(C)(C)C)ncn1.COC(=O)c1ccc(C(C)C)nn1.COc1cc(C(C)C)nc(C)n1.Cc1cc(C(C)C)nc(C(F)(F)F)n1.Cc1cc(C(C)C)nc(C)n1.Cc1cc(C(C)C)nc(Cl)n1.Cc1cc(C(C)C)nc(N(CCO)CCO)n1.Cc1cc(C(C)C)nc(N2C(CO)CCC2CO)n1.Cc1cc(C(C)C)nc(N2CCOCC2)n1.Cc1cc(C(C)C)ncn1.Cc1cnc(C(C)C)cn1.[H]/N=C(\OC)c1cnc(C(C)C)cn1 |
| InChI | InChI=1S/C14H23N3O2.C13H22N4O.C12H21N3O2.2C12H19N3O.C11H17N3O.C11H19N3O.C11H17N3.C9H11F3N2.C9H13N3O.C9H12N2O2.C9H14N2O.C9H14N2.C8H11ClN2.2C8H12N2/c1-9(2)13-6-10(3)15-14(16-13)17-11(7-18)4-5-12(17)8-19;1-11(2)12-9-15-13(10-14-12)17-5-3-16(4-6-17)7-8-18;1-9(2)11-8-10(3)13-12(14-11)15(4-6-16)5-7-17;1-9(2)11-8-10(3)13-12(14-11)15-4-6-16-7-5-15;1-9(2)11-7-12(14-8-13-11)15-5-3-10(16)4-6-15;1-9(2)10-3-4-11(13-12-10)14-5-7-15-8-6-14;1-11(2,3)9-7-10(13-8-12-9)14(4)5-6-15;1-9(2)10-7-11(13-8-12-10)14-5-3-4-6-14;1-5(2)7-4-6(3)13-8(14-7)9(10,11)12;1-6(2)7-4-12-8(5-11-7)9(10)13-3;1-6(2)7-4-5-8(11-10-7)9(12)13-3;1-6(2)8-5-9(12-4)11-7(3)10-8;1-6(2)9-5-7(3)10-8(4)11-9;1-5(2)7-4-6(3)10-8(9)11-7;1-6(2)8-5-9-7(3)4-10-8;1-6(2)8-4-7(3)9-5-10-8/h6,9,11-12,18-19H,4-5,7-8H2,1-3H3;9-11,18H,3-8H2,1-2H3;8-9,16-17H,4-7H2,1-3H3;8-9H,4-7H2,1-3H3;7-10,16H,3-6H2,1-2H3;3-4,9H,5-8H2,1-2H3;7-8,15H,5-6H2,1-4H3;7-9H,3-6H2,1-2H3;4-5H,1-3H3;4-6,10H,1-3H3;4-6H,1-3H3;5-6H,1-4H3;5-6H,1-4H3;4-5H,1-3H3;2*4-6H,1-3H3/b;;;;;;;;;10-9-;;;;;; |
| InChIKey | VEXCEXRFEGBINK-LJTRTGIZSA-N |
| XLogP | 27.19 |
| TPSA | 670.32 Ų |
| H-Bond Donors | 8 |
| H-Bond Acceptors | 55 |
| Rotatable Bonds | 36 |
| Heavy Atoms | 224 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3128.59 |
| LogP ≤ 5 | 27.19 |
| H-Bond Donors ≤ 5 | 8 |
| H-Bond Acceptors ≤ 10 | 55 |
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'} |
|---|